Sign in
Taking people in South KoreaNo phase

Tests removing inflamed lining tissue to reduce knee crepitus after replacement

Tests removing part of the knee lining in adults getting a total knee replacement.

Key facts

Who runs it
Gangnam Severance Hospital
Where
Seoul, South KoreaSee the site
Trial code
Registry title
Partial Synovectomy in Articular Side of Quadriceps Tendon Verified to Reduce Crepitus in Retrospective Study
Status
Recruiting
People taking part
78 people, planned
Started
16 Oct 2023
Planned end
6 Oct 2025
Type of study
Interventional, 2 groupsOne group gets no study treatment, for comparison.
Treatments tested
  • Prepectoral
  • Subpectoral
Record updated
21 February 2025

Who can take part

AI summary

From the trial's eligibility criteria. Machine-read from the registry text on this page, so it can be wrong. The registry text below and the trial team decide who can take part.

The trial is looking for adults who are planning to have both knees replaced with a posterior stabilized total knee replacement. One knee gets a partial synovium removal; the other knee does not.

Age
19 years and older
Sex
All sexes can join.
Disease stage
Both knees are planned for a posterior stabilized (PS) total knee replacement. The record does not give a disease stage.

Main reasons for not taking part

  • Lost to follow-up, including death
  • Unexpected complication, such as infection or a fracture around the implant
  • Patella resurfacing
  • Surgery cancelled
  • Too much difference in X-ray or physical findings between the two knees

The registry criteria, word for word

Show all 7 criteriaShow less

Who can take part

  • 1.Patients who scheduled to perform both total knee arthroplasty(TKA) using posteiror crucitate sustain type (PS)

Who cannot take part

  • Canceled surgical treatment
  • Unexpected complication (e.g) Infection, periprosthetic fracture)
  • Lost follow up (Including death of patient)
  • Patella resurfacing
  • Refused to enrolled study
  • Too much radiological or physicological variance shown between either knee

Where in South Korea

  • Gangnam Severance HospitalSeoul, South KoreaContact: Soon-Phill YoonTaking people

About the trial

What the trial wants to find out

Crepitus causing unsatisfied result to patients after posterior stabilized total knee arthroplasty. Recent retrospective study demonstrated removal of hyperplastic synovium in distal quadriceps caused reduce of crepitus. However, this study has limitation of time gap exist between arms, different in observation time and bias caused by retrospective review. Thus aim of this study is that by randomized trial, verified hyperplastic synovium in distal quadriceps causing crepitus.

Read full original descriptionShow less

Target enrolled patients in this study are scheduled to perform both total knee arthroplasty. Experimental group is randomized side (right or left) of knee, and control group is other side of knee. Both arms decided by randomized number table. Crepitus measured after 3mo, 6mo, 1year after surgical treatment

The 2 groups in the trial

  • Synovium removal groupTreatment being tested

    Treatment: Prepectoral and Subpectoral

  • Synovium sustain groupNo study treatment, for comparison

Questions to ask the study team

  1. How often do I need to come in, and for how long each time?
  2. Are travel costs paid?
  3. Can I keep my own doctor?
  4. What happens if I want to stop?

Contact the study team: see the registry record → Contacts and Locations

Print a page for my doctor

Data and sources

Registry record
Listed on ClinicalTrials.gov.How to verify a trial in the registry
Official title
Partial Synovectomy in Articular Side of Quadriceps Tendon Reduces Crepitus After Posterior Stabilized Total Knee Arthroplasty : a Randomized, Controlled Trial
Plain-language title
Tests removing inflamed lining tissue to reduce knee crepitus after replacementGenerated from the registry record. The registry title is the official one.
AI summary
From the trial's eligibility criteria. Read by machine on 12 November 2026.
Record updated
21 February 2025